Currently recognized genes for schizophrenia: High-resolution chromosome ideogram representation

Area of Science:

• Neurogenetics and Psychiatric Disorders
• Genomic Medicine and Bioinformatics

Background:

• Schizophrenia spectrum and other psychotic disorders involve complex genetic factors.
• Advances in genetic technology facilitate the identification of schizophrenia-associated genes.

Purpose of the Study:

• To compile a master list of known, clinically relevant, or susceptibility genes for schizophrenia.
• To analyze the underlying genetic architecture of schizophrenia through genome-wide pathway analysis.

Main Methods:

• Systematic literature search for schizophrenia and genetics keywords across medical literature, psychiatric websites, and genomic databases.
• Compilation of a list of 560 schizophrenia-associated genes, presented in tabular form with chromosome ideograms.
• Genome-wide pathway analysis using GeneAnalytics to assess biological mechanisms.

Main Results:

• Identified 560 genes contributing to schizophrenia.
• These genes impact diverse biological pathways including ion channels, metabolism, neurotransmitter function (dopamine, GABA, glutamate, serotonin), brain development, signaling, and immune function.
• Specific examples include CACNA1B, CYP1A2, NRG1, PIK3CA, and HLA-DRB1.

Conclusions:

• The identified genes provide a comprehensive resource for understanding schizophrenia's genetic basis.
• This genetic information can inform diagnosis, gene-based treatment strategies, and genetic counseling for families.
• Visual representation of gene distribution aids clinicians in diagnosis and risk assessment.